Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Some insurance companies cover some medications for the treatment of type 2 diabetes, but not all of them
Technical advances in radiation therapy for brain tumors
Novo Nordisk's blockbuster drug Ozempic's India launch is imminent, so are its generic versions ADVERTISEMENT On September 26, Danish pharma multinational Novo Nordisk got the Indian drug regulator Central Drugs Standard Control Organisation (CDSCO)s approval to sell its global blockbuster diabetes medicine Semaglutide (known under the brand name Ozempic) in India
Further improvement in postprandial glucose control with addition of exenatide or sitagliptin to combination therapy with insulin glargine and metformin: a proof-of-concept study
Avoid recapping the needle to prevent needle stick injury
Potassium
US$ 23.19
US$ 21.84
US$ 20.65
US$ 20.63
